{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T02:20:08Z","timestamp":1795054808703,"version":"4.10.2"},"reference-count":40,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2008,10,13]],"date-time":"2008-10-13T00:00:00Z","timestamp":1223856000000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2008,10]]},"abstract":"<jats:p>The present study aimed to identify polymorphic genes encoding carbonyl reductases (<jats:italic>CBR1<\/jats:italic>,<jats:italic>CBR3<\/jats:italic>) and investigate their influence on doxorubicin disposition in Asian breast cancer patients (<jats:italic>n<\/jats:italic>\u00a0=\u00a062). Doxorubicin (60\u00a0mg\/m<jats:sup>2<\/jats:sup>) was administered every 3\u00a0weeks for four to six cycles and the pharmacokinetic parameters were estimated using non\u2010compartmental analysis (WinNonlin). The Mann\u2013Whitney<jats:italic>U<\/jats:italic>\u2010test was used to assess genotypic\u2013phenotypic correlations. Five<jats:italic>CBR1<\/jats:italic>(\u2013<jats:italic>48G&gt;A<\/jats:italic>, c.<jats:italic>219G&gt;C<\/jats:italic>, c.<jats:italic>627C&gt;T<\/jats:italic>, c.693G&gt;A, +<jats:italic>967G&gt;A<\/jats:italic>) and<jats:italic>CBR3<\/jats:italic>(c.<jats:italic>11G&gt;A<\/jats:italic>, c.<jats:italic>255C&gt;T<\/jats:italic>, c.<jats:italic>279C&gt;T<\/jats:italic>, c.<jats:italic>606G&gt;A<\/jats:italic>, c.<jats:italic>730G&gt;A<\/jats:italic>) polymorphisms were identified. The<jats:italic>CBR1<\/jats:italic>D2 diplotypes were characterized by the presence of at least one variant allele at the c.<jats:italic>627C&gt;T<\/jats:italic>and +<jats:italic>967G&gt;A<\/jats:italic>loci. Patients in the<jats:italic>CBR1<\/jats:italic>D1 diplotype group had significantly higher clearance (CL) normalized to body surface area (BSA) (CL\/BSA[L\/h\/m<jats:sup>2<\/jats:sup>]: median 25.09; range 16.44\u201355.66) and significantly lower exposure levels; area under curve (AUC<jats:sub>0\u2013\u221e<\/jats:sub>\/dose\/BSA [h\/m<jats:sup>5<\/jats:sup>]; median 15.08; range 6.18\u201338.03) of doxorubicin compared with patients belonging to the<jats:italic>CBR1<\/jats:italic>D2 diplotype group (CL\/BSA[L\/h\/m<jats:sup>2<\/jats:sup>]; median 20.88; range 8.68\u201331.79,<jats:italic>P\u00a0=<\/jats:italic>\u00a00.014; and AUC<jats:sub>0\u2013\u221e<\/jats:sub>\/dose\/BSA[h\/m<jats:sup>5<\/jats:sup>]; median 21.35; range 9.82\u201367.17,<jats:italic>P\u00a0=<\/jats:italic>\u00a00.007 respectively). No significant influence of<jats:italic>CBR3<\/jats:italic>polymorphisms on the pharmacokinetics of doxorubicin were observed in Asian cancer patients. The present exploratory study shows that<jats:italic>CBR1<\/jats:italic>D2 diplotypes correlate with significantly higher exposure levels of doxorubicin, suggesting the possibility of lowered intracellular conversion to doxorubicinol in these patients. Further evaluation of carbonyl reductase polymorphisms in influencing the treatment efficacy of doxorubicin\u2010based chemotherapy in Asian cancer patients are warranted. (<jats:italic>Cancer Sci<\/jats:italic>2008; 99: 2045\u20132054)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2008.00903.x","type":"journal-article","created":{"date-parts":[[2008,10,13]],"date-time":"2008-10-13T09:24:55Z","timestamp":1223889895000},"page":"2045-2054","source":"Crossref","is-referenced-by-count":50,"title":["<i>CBR1<\/i>and<i>CBR3<\/i>pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients"],"prefix":"10.1111","volume":"99","author":[{"given":"Suman","family":"Lal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Sandanaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zee Wan","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.S.","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan Soon","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund J.D.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balram","family":"Chowbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,10,23]]},"reference":[{"key":"e_1_2_6_2_2","volume-title":"Structure, Mechanism, and Biochemistry","author":"Guengerich FP","year":"1995"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(77)90054-5"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.3109\/03602538008994021"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-2797(00)00196-4"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0030128"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(91)90143-7"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1996.0484z.x"},{"key":"e_1_2_6_9_2","first-page":"4646","article-title":"Protection against daunorubicin cytotoxicity by expression of a cloned human carbonyl reductase cDNA in K562 leukemia cells","volume":"15","author":"Gonzalez B","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-2797(02)00164-3"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(95)00124-I"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(99)00319-6"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200004000-00009"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1998.tb01463.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(78)90047-3"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.21.1"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(92)90268-W"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.014779"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.002006"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-2797(00)00242-8"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0090-9556(25)05924-0","article-title":"Adriamycin metabolism in man: Evidence from urinary metabolites","volume":"4","author":"Takanashi S","year":"1976","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198815010-00002"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-007-9050-6"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-2797(01)00257-5"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0731-7085(02)00442-9"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/25.14.2745"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-483X(99)00192-4"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.03.006"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3280ef698f"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-1809.2002.00112.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-2377"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/76211"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.006148"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(99)00322-6"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1080\/10245330701283991"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2008.00744.x"},{"key":"e_1_2_6_37_2","first-page":"4646","article-title":"Protection against daunorubicin cytotoxicity by expression of a cloned human carbonyl reductase cDNA in K562 leukemia cells","volume":"55","author":"Gonzalez B","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-4735-8_67"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.103846"},{"key":"e_1_2_6_40_2","first-page":"5158","article-title":"Human carbonyl reductase overexpression in the heart advances the development of doxorubicin\u2010induced cardiotoxicity in transgenic mice","volume":"60","author":"Forrest GL","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.10.3585"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2008.00903.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2008.00903.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T18:27:53Z","timestamp":1738434473000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2008.00903.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["10.1111\/j.1349-7006.2008.00903.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2008.00903.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}